Mike Roman Chairman of the Board & Chief Executive Officer Monish Patolawala Executive Vice President, Chief Financial & Transformation Officer 2022 Third Quarter Earnings Bruce Jermeland Senior Vice President, Investor Relations (unaudited) -- 1 of 16 -- 2 2022 Q3 Earnings – October 25, 2022. All rights reserved. Forward looking statement This presentation contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the coronavirus (COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2021, as updated by the Company's Current Report on Form 8-K dated April 26, 2022, and any subsequent quarterly reports on Form 10-Q (the "Reports"); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity improvements than estimated; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the proposed spin-off of the Company’s Health Care business, including whether the transaction will be completed, or if completed, will be on the expected terms; the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; the ability to satisfy the various closing conditions; potential business disruption; the diversion of management time; the impact of the transaction (or its pendency) on the Company’s ability to retain talent; potential impacts on the Company’s relationships with its customers, suppliers, employees, regulators and other counterparties; the ability to realize the desired tax treatment (including whether an Internal Revenue Service private letter ruling will be sought or obtained); the risk that any consents or approvals required will not be obtained; risks associated with financings that may be undertaken and indebtedness that may be incurred in connection with the transaction; and (16) matters relating to the voluntary chapter 11 proceedings of the Company’s subsidiary Aearo Technologies and certain of its affiliates (the “Aearo Entities”), including legal risks related to the chapter 11 proceedings; potential impacts to the Company’s reputation and its relationships with customers, suppliers, employees, regulators and other counterparties and community members; potential impacts to the Company’s liquidity or results of operations, including risks related to the amount that will be necessary to fully and finally resolve all of the Company’s obligations to make payments to resolve such claims under the terms of its funding and indemnification agreement with the Aearo Entities; and the Aearo Entities’ ability to navigate the chapter 11 proceedings to obtain approval and consummation of a plan of reorganization. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). The Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments. This presentation refers to certain non-GAAP financial measures. Refer to 3M’s October 25, 2022, press release for descriptions of non-GAAP financial measures such as free cash flow, adjusted free cash flow, free cash flow conversion, adjusted free cash flow conversion, net debt, adjusted EBITDA, and various measures that adjust for the impacts of special items. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in that press release. Note on non-GAAP financial measures -- 2 of 16 -- 3 2022 Q3 Earnings – October 25, 2022. All rights reserved. Executing in a challenging environment while positioning 3M for long-term growth • Q3 performance – Delivered year–on-year organic growth, adjusted operating margins and cash flow while managing through an uncertain global macroeconomic and geopolitical environment, and continued U.S. dollar strength – Executing our strategy to drive growth, improve operational execution, and generate strong cash flow to create long-term value for customers, employees and shareholders – Updating full-year expectations to reflect continued U.S. dollar strength and ongoing macroeconomic and geopolitical uncertainty • Positioning our company for long-term growth – Continue to invest in growth, productivity, and sustainability – Completed Food Safety divestiture; received ~$1B in consideration and reduced outstanding shares by 16M via exchange offer – Established dedicated team to create a leading global diversified healthcare company and a more focused 3M – Divested consumer skin care brands Neobun™ and Neoplast™ in Thailand • Making progress on Combat Arms litigation strategy and proactively managing PFAS Q3 2022 Organic growth +2.0% Includes (~1.4 ppt) headwind from disposable respirator decline Adjusted operating margin 21.5% Adjusted earnings per share $2.69 -- 3 of 16 -- 4 2022 Q3 Earnings – October 25, 2022. All rights reserved. Q3 2022 operating margin and EPS +9.0% Adjusted operating margin Adjusted earnings per share Commentary Q3 2021 21.1% $2.58 Total organic growth/ productivity/other +2.9% +$0.41 Disposable respirator -0.3% -$0.07 • Decline in COVID-related disposable respirator demand Remaining organic growth/ productivity/other +3.2% +$0.48 • Strong pricing, spending discipline, and ongoing benefits from productivity actions • Continued headwinds from global supply chain challenges and geopolitical impacts • Investments in growth, productivity, and sustainability Raw material -2.6% -$0.31 • Raw material and logistics cost inflation FX +0.1% -$0.12 • Increasing U.S. dollar strength Divestiture* 0.0% -$0.02 • Food Safety divestiture; Aearo Technologies deconsolidation Other expense/income NA $0.00 • Primarily non-operating pension expense offset by lower net interest expense Adjusted tax rate** NA +$0.07 • Q3 2022 adjusted tax rate of 16.2% versus 18.5% in Q3 2021 Shares outstanding NA +$0.08 • Average diluted shares down ~3% Q3 2022 21.5% $2.69 * Includes lost income from divested businesses and remaining stranded costs (net of transition arrangement income). ** The effect of income taxes on items that had specific tax rates are reflected within their respective impacts in the table above. -- 4 of 16 -- 5 2022 Q3 Earnings – October 25, 2022. All rights reserved. Adjusted free cash flow. • Q3: $1.4B, down 16% YoY; YTD: $3.0B, down 35% YoY Adjusted free cash flow conversion • Expect full-year adjusted free cash flow conversion in the range of 85% to 95% • Q3: 88%, down 19 ppts YoY; YTD: 68%, down 28 ppts YoY • Q3 YoY decline impacted by working capital; increase in capex for growth and sustainability investments; cash impact from capitalization of R&D for U.S. tax purposes Capital expenditures • Q3: $435M, up 27% YoY; YTD: $1.2B, up 19% YoY • Full-year range of $1.75B to $1.85B vs. $1.7B to $2.0B prior Net debt • Q3: $12.1B, down 3% YoY Capital returned to shareholders • Q3: dividends $850M; share repurchases $155M (resumed following Food Safety divestiture) • YTD: dividends $2.6B; share repurchases $0.9B • Reduced outstanding shares by 16M via exchange offer due to Food Safety divestiture Q3 2022 cash flow and balance sheet Adjusted free cash flow $1.4B Adjusted free cash flow conversion 88% Cash returned to shareholders $1.0B -- 5 of 16 -- 6 2022 Q3 Earnings – October 25, 2022. All rights reserved. Safety & Industrial Transportation & Electronics Health Care Consumer Business Group performance -- 6 of 16 -- 7 2022 Q3 Earnings – October 25, 2022. All rights reserved. Business Group performance Q3 2022 Organic growth Adjusted operating margin Commentary Safety & Industrial 1.7% 23.2% • Organic growth in automotive aftermarket, roofing granules, electrical markets, abrasives, closure and masking systems, and industrial adhesives and tapes; personal safety declined • Disposable respirator sales declined ~$130M, or -34% organically YoY; reduced segment organic growth by 4.6 ppts • Adjusted operating margins +2.5 ppts YoY; benefits from selling price actions, strong spending discipline and restructuring actions more than offset increased raw materials/logistics costs and manufacturing productivity headwinds Transportation & Electronics 3.0% 21.2% • Organic growth in automotive OEM, commercial solutions, and advanced materials; electronics and transportation safety declined • Semiconductor supply chain challenges continue; consumer electronics demand softening • Operating margins +2.5 ppts YoY; benefits from selling price actions, strong spending discipline and restructuring actions more than offset increased raw materials/logistics costs and manufacturing productivity headwinds Health Care 1.7% 21.8% • Organic growth in medical solutions, food safety, separation and purification sciences, and health information systems; oral care declined • Operating margins -1.7 ppts YoY; impacted by increased raw materials/logistics costs, manufacturing productivity headwinds, and investments; partially offset by selling price actions, strong spending discipline, and benefits from productivity actions • Adjusted EBITDA margin of 29.1% • Healthcare elective procedure and oral care volumes approximately 90% of pre-COVID levels Consumer 1.5% 21.3% • Organic growth in consumer health and safety, stationery and office, and home care; home improvement declined • Operating margins -20 bps YoY; benefits from selling price actions, strong spending discipline, and restructuring actions mostly offset increased raw materials/logistics and outsourced hardgoods manufacturing costs, manufacturing productivity headwinds, and investments -- 7 of 16 -- 8 2022 Q3 Earnings – October 25, 2022. All rights reserved. 2022 outlook -- 8 of 16 -- 9 2022 Q3 Earnings – October 25, 2022. All rights reserved. 2022 planning estimates Updated expectations reflect ongoing U.S. dollar strength and macro uncertainty Organic sales growth 1.5% to 2.0% Adjusted earnings per share $10.10 to $10.35 Adjusted free cash flow conversion 85% to 95% 2022 full-year Trends to watch for 2023 • IPI & GDP: ~3%; ongoing fluid and uncertain macroeconomic and geopolitical environment • Disposable respirator impact of -1.5% on organic growth • Consumer spending softening due to inflationary pressures • FX impact on total sales growth: -4.5% vs. -4% prior; increasing U.S. dollar strength • Monitoring Greater China region COVID-related actions • Raw material/logistics inflation of $750M to $850M, unchanged • Continued global supply chain challenges • Adjusted tax rate: 17.5% to 18.5% vs. 18.5% to 19.5% prior • Macroeconomic and geopolitical environment • Foreign currency exchange trends • Evolving COVID-related impacts including on disposable respirator demand • Increasing pace of secular end-market trends including in automotive, electronics, safety, digitization, and sustainability • Easing raw material/logistics/labor inflation • Stabilizing global supply chain environment Implied Q4 • Total sales in range of $7.9B to $8.2B; includes -7% FX impact • Organic growth in range of 1.0% to 3.0%; includes -2% impact from decline in disposable respirator demand • Adjusted operating margins in range of 20% to 21% -- 9 of 16 -- 10 2022 Q3 Earnings – October 25, 2022. All rights reserved. Q&A Mike Roman Chairman of the Board & Chief Executive Officer Monish Patolawala Executive Vice President, Chief Financial & Transformation Officer Bruce Jermeland Senior Vice President, Investor Relations -- 10 of 16 -- 11 2022 Q3 Earnings – October 25, 2022. All rights reserved. Appendix -- 11 of 16 -- 12 2022 Q3 Earnings – October 25, 2022. All rights reserved. Q3 2022 P&L ($M) Q3 2022 Q3 2021 Change Sales $8,619 $8,942 -3.6% Gross profit $3,891 $4,089 -4.8% % to sales 45.1% 45.7% -0.6 pts SG&A $1,998 $1,819 +9.8% % to sales 23.1% 20.3% +2.8 pts R&D & related $461 $482 -4.2% % to sales 5.4% 5.4% — pts Gain on sale of businesses $(2,724) — +100.0% % to sales -31.6% — -31.6 pts Operating income $4,156 $1,788 +132.5% % to sales 48.2% 20.0% +28.2 pts Net income $3,859 $1,434 +169.1% GAAP earnings per share $6.77 $2.45 +176.8% -- 12 of 16 -- 13 2022 Q3 Earnings – October 25, 2022. All rights reserved. Q3 2022 sales recap Americas EMEA APAC Worldwide Organic growth +2.3% -0.3% +2.8% +2.0% Acquisitions/divestitures -0.7% -0.2% -0.5% -0.5% FX -0.5% -12.9% -8.3% -5.1% Total growth +1.1% -13.4% -6.0% -3.6% U.S. Canada Mexico Brazil China/HK Japan Organic growth —% +14% +14% +11% +8% —% -- 13 of 16 -- 14 2022 Q3 Earnings – October 25, 2022. All rights reserved. Business segment information ($M) Net Sales Q3 2022 Sales Growth Adjusted Operating Income* Adjusted Operating Margin* Business groups Q3 2022 Q3 2021 Organic growth FX M&A Total Sales Change Q3 2022 Q3 2021 Percent change Q3 2022 Q3 2021 Safety & Industrial $2,894 $3,005 1.7% -5.4% —% -3.7% $673 $622 8.2% 23.2% 20.7% Transportation & Electronics $2,239 $2,327 3.0% -6.0% -0.8% -3.8% $474 $435 9.1% 21.2% 18.7% Health Care $2,076 $2,173 1.7% -4.8% -1.3% -4.4% $452 $510 -11.3% 21.8% 23.5% Consumer $1,409 $1,434 1.5% -3.2% —% -1.7% $299 $308 -3.0% 21.3% 21.5% Total Operating Business Segment $1,898 $1,875 Corporate & Unallocated $1 $3 $(43) $10 Total $8,619 $8,942 2.0% -5.1% -0.5% -3.6% $1,855 $1,885 -1.6% 21.5% 21.1% *"Safety & Industrial", "Corporate & Unallocated", "Total Operating Business Segment" and "Total" provided on an adjusted basis Organic growth = organic volume + price -- 14 of 16 -- 15 2022 Q3 Earnings – October 25, 2022. All rights reserved. Additional sales detail ($M) Net Sales Business groups Q3 2022 Q3 2021 Abrasives 339 332 Automotive Aftermarket 316 293 Closure and Masking Systems 266 264 Electrical Materials 331 316 Industrial Adhesives & Tapes 598 594 Personal Safety 922 1,098 Roofing Granules 122 109 Other Safety & Industrial — (1) Total Safety & Industrial Business Group 2,894 3,005 Advanced Materials 297 303 Automotive & Aerospace 437 415 Commercial Solutions 459 444 Electronics 813 917 Transportation Safety 233 247 Other Transportation & Electronics — 1 Total Transportation & Electronics Business Group 2,239 2,327 ($M) Net Sales Business groups Q3 2022 Q3 2021 Food Safety 63 94 Health Information Systems 312 309 Medical Solutions 1,150 1,169 Oral Care 314 357 Separation & Purification Sciences 229 243 Other Health Care 8 1 Total Health Care Business Group 2,076 2,173 Consumer Health & Safety 146 145 Home Care 265 272 Home Improvement 663 680 Stationery & Office 335 338 Other Consumer — (1) Total Consumer Business Group 1,409 1,434 Corporate & Unallocated 1 3 Total 3M 8,619 8,942 -- 15 of 16 -- -- 16 of 16 --